Late‐onset hematological complications post <scp>COVID</scp>‐19: An emerging medical problem for the hematologist
Eleni Korompoki, Maria Gavriatopoulou, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, Meletios Α. Dimopoulos, Evangelos Terpos
Abstract
Coronavirus disease 19 (COVID-19) is considered a multisystemic disease. Several studies have reported persistent symptoms or late-onset complications after acute COVID-19, including post-COVID-19 hematological disorders. COVID-19-induced coagulopathy, an immunothrombotic state, has been linked to thromboembolic and hemorrhagic events. Late-onset thrombocytopenia related to immune system dysregulation has also been reported as a rare manifestation post COVID-19. Close monitoring of laboratory dynamics is considered essential to identify timely abnormal values that need further investigation, providing supportive care whenever indicated. The role of hematologists is essential in terms of the multidisciplinary approach of long COVID-19. This review summarizes all the available evidence on post-acute COVID-19 hematological complications.